Man Group
TDOC icon

Man Group’s Teladoc Health TDOC Stock Holding History

Man Group’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-500
Closed -$36K – 2399
2022
Q1 		$36K Sell
500
-2,800
-85% -$202K ﹤0.01% 2136
2021
Q4 		$303K Buy
+3,300
New +$394K ﹤0.01% 1678

Other funds holding TDOC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $123B AUM 45.23% 1-Year Est. Return

Man Group's TDOC Position: Q2 2026 in Review

Man Group reduced its Teladoc Health (TDOC) stake by 73% in Q2 2026, selling an estimated $14.7M and leaving 811,385 shares worth $6.88M. The position accounts for 0.01% of the portfolio, ranked #974.

Man Group first reported a position in TDOC in Q2 2018 and has held it in 28 quarters since. The position peaked at $42.8M in Q4 2023. 348 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Man Group held 811,385 shares of Teladoc Health worth $6.88M as of Q2 2026.
  • Man Group sold 2,210,165 Teladoc Health shares in Q2 2026, an estimated $14.7M.
  • Teladoc Health made up 0.01% of Man Group's portfolio in Q2 2026, its #974 holding.
  • Man Group first reported a position in Teladoc Health in Q2 2018 and has held it in 28 quarters since.
  • Man Group's Teladoc Health position peaked at $42.8M in Q4 2023.
  • 348 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.